CompletedNCT06366438
A study of Two Universal Programs for Parents of Teenagers
This study is completed. It focuses on mental health and currently lists study information in Sweden.
Mental healthOtherFrom 13 Years to 19 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Active Not RecruitingNCT05102864
A study of Two-Week Brain Stimulation for Teenagers With ADHD
This study is active but not recruiting. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 12 Years to 18 Years
CompletedNCT06372210
A study to Assess a Wearable Patch's Functioning to Detect Medication Ingestion
This study is completed. It focuses on depression and currently lists study information in the United States.
Depression, Schizophrenia, ...OtherOver 18 Years
CompletedNCT03257865
A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes, Associated With Bipolarity I
This study is completed. It focuses on bipolarity and currently lists study information in Croatia, Ukraine, and the United States.
BipolarityOtherFrom 18 Years to 65 Years
CompletedNCT07314333
A study to Assess How Centanafadine Interacts With Stimulants in the Body
This study is completed. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 18 Years to 55 Years
CompletedNCT02282761
A study to Assess the Antipsychotic Efficacy of ITI-007
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
SchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT02469155
A study to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
SchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT04786730
A study to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
This study is completed in the United States. It focuses on ADHD.
ADHDOtherFrom 4 Years to 12 Years
CompletedNCT04398225
A study to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder
This study is completed. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 4 Years to 12 Years
CompletedNCT07253441
A study to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels
This study is completed in the United States. It focuses on ADHD.
ADHDOtherFrom 18 Years to 55 Years
CompletedNCT01101464
A study to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)
This study is completed in Global. It focuses on schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT03605836
A study Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
This study is completed. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 18 Years to 55 Years